Mird-237

: The "MIRD" prefix identifies the specific series or label, while "237" indicates the episode or volume number within that series.

Treatment response assessment: Correlating spatial dose metrics (e.g., dose–volume histograms, voxel-based dose–response analysis) with biological or radiographic outcomes. MIRD-237

The MIRD formalism provides the essential mathematical framework for internal dosimetry, shifting nuclear medicine from a "one size fits all" empirical approach to . As noted in research from MDPI Pharmaceuticals , this transition is vital for modern therapies like radioembolization or molecular radiotherapy, where precise dose calculations are required to maximize tumor destruction while sparing healthy tissue. Key Components of the MIRD System : The "MIRD" prefix identifies the specific series

In nuclear medicine, MIRD refers to a committee and a standard methodology for calculating the radiation dose absorbed by human organs from internal radionuclides. However, "MIRD-237" is not a recognized publication or standard number within that scientific framework. As noted in research from MDPI Pharmaceuticals ,

MIRD-237 represents a comprehensive effort to collate and evaluate the dosimetry data for a wide range of radiopharmaceuticals. This report is not only a valuable resource for nuclear medicine professionals but also serves as a guide for researchers and clinicians involved in the development, application, and regulation of radiopharmaceuticals.